デフォルト表紙
市場調査レポート
商品コード
1701341

核酸分離および精製の市場規模、シェア、動向分析レポート:製品タイプ別、用途別、手法別、最終用途別、地域別、セグメント予測、2025年~2030年

Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application (Precision Medicine, Diagnostics, Drug discovery & Development), By Method, By End-use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 135 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
核酸分離および精製の市場規模、シェア、動向分析レポート:製品タイプ別、用途別、手法別、最終用途別、地域別、セグメント予測、2025年~2030年
出版日: 2025年03月19日
発行: Grand View Research
ページ情報: 英文 135 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

核酸分離および精製の市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の核酸分離および精製市場規模は2030年までに97億7,000万米ドルに達し、2025年から2030年までのCAGRは9.61%を記録すると推定されています。

この成長の背景には、がん患者数の増加、慢性疾患の流行、バイオテクノロジーやライフサイエンス研究に対する官民の資金提供の増加があります。また、自動化や技術の進歩、遺伝子組み換え作物や生物に対する需要の高まりも市場成長に寄与しています。例えば、2023年12月、HiMedia Labs社は、核酸抽出における磁気ビーズベースのシステムの意義と有効性を詳しく説明し、様々な最終用途産業における核酸分離および精製の応用について述べています。

糖尿病、がん、関節リウマチ、神経疾患、自己免疫疾患など、複数の疾患を治療するために開発された精密医薬品の数。この市場は、遺伝子の操作を助ける様々な新しいアプローチで導入されています。例えば、がん、遺伝性疾患、自己免疫疾患などの病態における遺伝子の過剰発現や変異に対処するために、各社はsmall interfering RNA(siRNA)などの核酸を送達するプラットフォームに投資しています。研究者たちは常に、患者にとって効果的な治療法を見つけようとしています。今度の新しい精密治療は、不治の病を治療する鍵を握っているかもしれないです。従って、核酸と核酸分離および精製製品・技術の使用は、精密医薬品の開発にとって非常に重要です。

製薬会社やバイオテクノロジー企業によるヒトゲノム研究開発(R&D)は、病気の診断や治療法の開発を大きく変えました。核酸分離および精製キット・機器市場は、新薬の発見、標的同定、検査、特にゲノム編集において極めて重要です。研究開発および創薬プロジェクトへの多額の投資が、この分野における企業間の競争敵対関係を促進しています。治療法開発のための新興技術の採用が増加していることから、核酸の単離・精製は遺伝子組み換えによる医薬品や治療法の製造において重要なステップとなっており、市場開拓のさらなる促進が期待されます。成長に寄与する主な要因には、治療薬の同定と検証のためのCRISPR技術の広範な使用、改善された動物実験モデルの作成、前臨床試験における創薬のための研究開発コストの削減などがあります。

核酸分離および精製市場レポート・ハイライト

  • 製品別では、DNA/RNA抽出・精製用キットの需要増により、キット・試薬が2024年に最大の収益シェアを占めました。
  • 機器分野は予測期間中CAGRで大幅な成長が見込まれます。
  • タイプ別では、DNA分離・精製分野が2024年に最大の収益シェアを占めました。
  • RNA分離・精製分野は、予測期間中に大きな成長が見込まれます。この成長は、遺伝子発現プロファイリング、シークエンシング、臨床診断への応用によるものです。
  • 用途別では、診断分野が2024年に市場をリードしました。これは、ルーチンサンプル処理における病原体同定のためのDNAおよびRNA分離の用途が増加しているためです。
  • 創薬・開発分野は、慢性疾患やその他の疾患の増加により、予測期間中に大きなCAGRで成長すると予測されています。
  • メソッド別では、磁気ビーズ・セグメントが2024年の市場をリードしました。これは、その高い有効性とさまざまな分野での応用によるものです。
  • カラムベースのセグメントは、予測期間中に大きな成長率を記録する見込みです。
  • 最終用途別では、病院・診断センター分野が2024年に最大の収益シェアを占めました。この成長は、幅広いヘルスケアセグメントで核酸の使用が増加しているためです。
  • 製薬・バイオテクノロジー企業セグメントは、予測期間中に最も速いCAGRを記録すると予測されています。
  • 地域別では、北米が世界のNAIP市場を独占しているが、これは政府支援の活用、有利な規制枠組み、一貫した研究開発努力などの要因によるものです。
  • アジア太平洋は、中国、日本、インドなどの国々で行われているいくつかのビジネスイニシアチブのため、予測期間中に最も速いCAGRで成長すると予想されています。
  • 2023年12月、Thermo Fisher Scientific Inc.は、自動核酸精製装置Thermo Scientific KingFisher Apex DxとApplied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kitを発売しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 核酸分離および精製市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19分析

第4章 製品別ビジネス分析

  • 核酸分離および精製市場:製品変動分析
  • キットと試薬
  • 機器
    • マニュアル
    • 自動

第5章 タイプ別ビジネス分析

  • 核酸分離および精製市場:タイプ変動分析
  • DNAの分離と精製
    • ゲノムDNAの分離と精製
    • プラスミドDNAの分離と精製
    • ウイルスDNAの分離と精製
    • その他
  • RNAの分離と精製
    • miRNAの分離と精製
    • mRNAの分離と精製
    • 全RNAの分離と精製
    • その他

第6章 用途別ビジネス分析

  • 核酸分離および精製市場:用途変動分析
  • 精密医療
  • 診断
  • 医薬品の発見と開発
  • 農業と動物調査
  • その他のアプリケーション

第7章 手法別ビジネス分析

  • 核酸分離および精製市場:手法変動分析
  • カラムベース
  • 磁気ビーズ
  • 試薬ベース

第8章 最終用途別ビジネス分析

  • 核酸分離および精製市場:最終用途変動分析
  • 学術調査機関
  • 製薬およびバイオテクノロジー企業
  • 受託研究機関
  • 病院と診断センター
  • その他の用途

第9章 地域別ビジネス分析

  • 核酸分離および精製市場:地域別展望
  • 北米
    • 北米市場推計・予測2018-2030
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州市場推計・予測2018-2030
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • アジア太平洋市場推計・予測2018年-2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測2018-2030
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測2018-2030
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 企業分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/リスト
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • Merck KGaA
    • Agilent Technologies
    • Bio-Rad Laboratories, Inc.
    • Takara Bio Inc.
    • Promega Corporation
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 7 North America nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 10 U.S. nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 12 U.S. nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 17 Canada nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
  • Table 19 Europe nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 20 Europe nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 23 Europe nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 26 Germany nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 28 Germany nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 31 UK nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 33 UK nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 34 France nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 35 France nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 36 France nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 37 France nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 38 France nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 41 Italy nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 42 Italy nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 43 Italy nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Spain nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 45 Spain nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 46 Spain nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 47 Spain nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 48 Spain nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 51 Denmark nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 53 Denmark nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Sweden nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 56 Sweden nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 57 Sweden nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 58 Sweden nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Norway nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 60 Norway nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 61 Norway nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 62 Norway nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 63 Norway nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 70 China nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 71 China nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 72 China nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 73 China nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 74 China nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Japan nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 76 Japan nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 77 Japan nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 78 Japan nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 79 Japan nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 80 India nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 81 India nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 82 India nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 83 India nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 84 India nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 85 South Korea nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Korea nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 87 South Korea nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 88 South Korea nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 89 South Korea nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Australia nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 91 Australia nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 92 Australia nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 93 Australia nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 94 Australia nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Thailand nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 96 Thailand nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 97 Thailand nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 98 Thailand nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 99 Thailand nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Latin America nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 101 Latin America nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 102 Latin America nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 103 Latin America nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 104 Latin America nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 105 Brazil nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 106 Brazil nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 107 Brazil nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 108 Brazil nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 109 Brazil nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 110 Mexico nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 111 Mexico nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 112 Mexico nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 113 Mexico nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 114 Mexico nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Argentina nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 116 Argentina nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 117 Argentina nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 118 Argentina nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 119 Argentina nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 120 MEA nucleic acid isolation and purification market, by country, 2018 - 2030 (USD Million)
  • Table 121 MEA nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 122 MEA nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 123 MEA nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 124 MEA nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 125 MEA nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 126 South Africa nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 127 South Africa nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 128 South Africa nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 129 South Africa nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 130 South Africa nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 131 Saudi Arabia nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 136 UAE nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 137 UAE nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 138 UAE nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 139 UAE nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 140 UAE nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)
  • Table 141 Kuwait nucleic acid isolation and purification market, by product, 2018 - 2030 (USD Million)
  • Table 142 Kuwait nucleic acid isolation and purification market, by type, 2018 - 2030 (USD Million)
  • Table 143 Kuwait nucleic acid isolation and purification market, by application, 2018 - 2030 (USD Million)
  • Table 144 Kuwait nucleic acid isolation and purification market, by method, 2018 - 2030 (USD Million)
  • Table 145 Kuwait nucleic acid isolation and purification market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD product & servicing for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Parent market outlook
  • Fig. 9 Nucleic acid isolation and purification market driver impact
  • Fig. 10 Nucleic acid isolation and purification market restraint impact
  • Fig. 11 Nucleic acid isolation and purification market: Product outlook and key takeaways
  • Fig. 12 Nucleic acid isolation and purification market: Product movement analysis
  • Fig. 13 Kits & reagents market estimates and forecast, 2018 - 2030
  • Fig. 14 Instruments market estimates and forecast, 2018 - 2030
  • Fig. 15 Manual market estimates and forecast, 2018 - 2030
  • Fig. 16 Automatic market estimates and forecast, 2018 - 2030
  • Fig. 17 Nucleic acid isolation and purification market: Type outlook and key takeaways
  • Fig. 18 Nucleic acid isolation and purification market: Type movement analysis
  • Fig. 19 DNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 20 Genomic DNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 21 Plasmid DNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 22 Viral DNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 23 Other market estimates and forecast, 2018 - 2030
  • Fig. 24 RNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 25 miRNA Isolation & Purification market estimates and forecast, 2018 - 2030
  • Fig. 26 mRNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 27 Total RNA isolation & purification market estimates and forecast, 2018 - 2030
  • Fig. 28 Other market estimates and forecast, 2018 - 2030
  • Fig. 29 Nucleic acid isolation and purification market: Application outlook and key takeaways
  • Fig. 30 Nucleic acid isolation and purification market: Application movement analysis
  • Fig. 31 Precision medicine market estimates and forecast, 2018 - 2030
  • Fig. 32 Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 33 Drug discovery & development market estimates and forecast, 2018 - 2030
  • Fig. 34 Agriculture and animal research market estimates and forecast, 2018 - 2030
  • Fig. 35 Other applications market estimates and forecast, 2018 - 2030
  • Fig. 36 Nucleic acid isolation and purification market: Method outlook and key takeaways
  • Fig. 37 Nucleic acid isolation and purification market: Method movement analysis
  • Fig. 38 Column based market estimates and forecast, 2018 - 2030
  • Fig. 39 Magnetic beads market estimates and forecast, 2018 - 2030
  • Fig. 40 Reagent based market estimates and forecast, 2018 - 2030
  • Fig. 41 Others applications market estimates and forecast, 2018 - 2030
  • Fig. 42 Nucleic acid isolation and purification market: End use outlook and key takeaways
  • Fig. 43 Nucleic acid isolation and purification market: End use movement Analysis
  • Fig. 44 Academic research institutes market estimates and forecasts,2018 - 2030
  • Fig. 45 Pharmaceutical - biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 46 Contract research organizations laboratories market estimates and forecasts,2018 - 2030
  • Fig. 47 Hospitals and diagnostic centers market estimates and forecasts, 2018 - 2030
  • Fig. 48 Other end-use market estimates and forecasts,2018 - 2030
  • Fig. 49 Global nucleic acid isolation and purification market: Regional outlook and key takeaways
  • Fig. 50 Global nucleic acid isolation and purification market: Regional movement analysis
  • Fig. 51 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-580-9

Nucleic Acid Isolation And Purification Market Growth & Trends:

The global nucleic acid isolation and purification market size is estimated to reach USD 9.77 billion by 2030, registering a CAGR of 9.61% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing number of cancer cases, chronic diseases prevalence, and rising public-private funding for biotechnology and life sciences research. In addition, advancements in automation and technology, and growing demand for genetically modified crops and organisms also contribute to the market growth. For instance, in December 2023, HiMedia Labs elaborated the significance and efficacy of magnetic bead-based systems in nucleic acid extraction and applying nucleic acid isolation and purification in various end-use industries.

The number of precision medicines developed for treating multiple diseases, such as diabetes, cancer, rheumatoid arthritis, neurological diseases, and autoimmune diseases. This market is introduced with the various new approaches, aiding the manipulation of genes. For instance, the companies are investing in a platform that delivers nucleic acids, such as small interfering RNAs (siRNAs), to address gene overexpression and mutations in conditions such as cancer, genetic disorders, and autoimmune diseases. Researchers are constantly trying to find effective therapeutics for patients. The upcoming new precision therapies may hold the key to treat incurable diseases. The use of nucleic acids and nucleic acid isolation & purification products and technologies are, therefore, very crucial for developing precision medicines.

The research and development (R&D) efforts in human genomics conducted by pharmaceutical and biotechnology companies have significantly transformed disease diagnosis and treatment development. The nucleic acid isolation and purification kits and instruments market is crucial in new drug discovery, target identification, and testing, particularly in genome editing. Substantial investments in R&D and drug discovery projects drive the competitive rivalry among companies in this space. The increasing adoption of emerging technologies for therapy development is expected to further drive market growth, with nucleic acid isolation and purification serving as a key step in manufacturing drugs and therapies through recombinant genetics. Key factors contributing to growth include the widespread use of CRISPR technology for identifying and validating therapeutics, creating improved animal testing models, and reducing the cost of research and development for drug discovery in preclinical trials.

Nucleic Acid Isolation And Purification Market Report Highlights:

  • Based on product, kits & reagents dominated the market with a largest revenue share in 2024, owing to the growing demand for kits for DNA/RNA extraction and purification.
  • The instruments segment is expected to grow at a significant CAGR over the forecast period.
  • Based on type, the DNA isolation and purification segment held the largest revenue share in 2024, owing to its variety of applications in the molecular biology field.
  • The RNA isolation and purification segment is anticipated to witness a significant growth over the forecast period. The growth is attributed to its applications in gene expression profiling, sequencing, and clinical diagnostics.
  • Based on application, the diagnostic segment led the market in 2024, owing to the rising application of DNA and RNA isolation for identifying pathogens in routine sample processing.
  • The drug discovery & development segment is expected to grow at the significant CAGR over the forecast period, due to the increasing number of chronic diseases and other disorders.
  • Based on method, the magnetic beads segment led the market in 2024. This can be attributed to its high efficacy and applications in a variety of fields.
  • The column-based segment is expected to register a significant growth rate during the forecast period.
  • Based on the end-use, the hospitals and diagnostics centers segment held the largest revenue share in 2024. The growth is due to the increased use of nucleic acid in a broad range of healthcare segments.
  • The pharmaceutical and biotechnology companies segment is expected to register the fastest CAGR during the projected period.
  • Based on region, North America dominated the global NAIP market, owing to factors such as leveraged government support, a favorable regulatory framework, and consistent R&D efforts.
  • Asia Pacific is expected to grow at the fastest CAGR during the forecast period, due to several business initiatives undertaking in countries such as China, Japan, and India.
  • In December 2023, Thermo Fisher Scientific Inc. launched an automatic nucleic acid purification instrument, Thermo Scientific KingFisher Apex Dx, and Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit to isolate and purify bacterial and viral pathogens from biological samples.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. Method
    • 1.2.5. End use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Nucleic Acid Isolation And Purification Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of cancer, genetic disorders, and infectious diseases
      • 3.2.1.2. Increase in public-private funding for biotechnology and life science research
      • 3.2.1.3. Advancements in automation
      • 3.2.1.4. Growth in NGS technologies
      • 3.2.1.5. Growing demand for genetically modified crops and organisms
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Expensive instruments and consequent low penetration in emerging countries
      • 3.2.2.2. Challenges related to the use of big data and bioinformatics
  • 3.3. Industry Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Analysis

Chapter 4. Product Business Analysis

  • 4.1. Nucleic Acid Isolation and Purification Market: Product Movement Analysis
  • 4.2. Kits & Reagents
    • 4.2.1. Kits & reagents market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.3.2. Manual
      • 4.3.2.1. Manual market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.3.3. Automatic
      • 4.3.3.1. Automatic market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Type Business Analysis

  • 5.1. Nucleic Acid Isolation and Purification Market: Type Movement Analysis
  • 5.2. DNA Isolation & Purification
    • 5.2.1. DNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.2.2. Genomic DNA Isolation & Purification
      • 5.2.2.1. Genomic DNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.2.3. Plasmid DNA Isolation & Purification
      • 5.2.3.1. Plasmid DNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.2.4. Viral DNA Isolation & Purification
      • 5.2.4.1. Viral DNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.2.5. Other
      • 5.2.5.1. Other market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.3. RNA Isolation & Purification
    • 5.3.1. RNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.3.2. miRNA Isolation & Purification
      • 5.3.2.1. miRNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.3.3. mRNA Isolation & Purification
      • 5.3.3.1. mRNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.3.4. Total RNA Isolation & Purification
      • 5.3.4.1. Total RNA isolation & purification market estimates and forecasts 2018 - 2030 (USD Million)
    • 5.3.5. Other
      • 5.3.5.1. Other market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Nucleic Acid Isolation and Purification Market: Application Movement Analysis
  • 6.2. Precision Medicine
    • 6.2.1. Precision medicine market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.3. Diagnostics
    • 6.3.1. Diagnostics market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Drug Discovery & Development
    • 6.4.1. Drug discovery & development market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Agriculture and Animal Research
    • 6.5.1. Agriculture and animal research market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Other applications market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Method Business Analysis

  • 7.1. Nucleic Acid Isolation and Purification Market: Method Movement Analysis
  • 7.2. Column Based
    • 7.2.1. Column based medicine market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.3. Magnetic Beads
    • 7.3.1. Magnetic beads market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Reagent Based
    • 7.4.1. Reagent based market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. End Use Business Analysis

  • 8.1. Nucleic Acid Isolation and Purification Market: End Use Movement Analysis
  • 8.2. Academic Research Institutes
    • 8.2.1. Academic research institutes market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3. Pharmaceutical and Biotechnology Companies
    • 8.3.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4. Contract Research Organizations
    • 8.4.1. Contract research organizations market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5. Hospitals and Diagnostic Centers
    • 8.5.1. Hospitals and diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.6. Other End-use
    • 8.6.1. Other end-use market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. 4.1. Nucleic Acid Isolation and Purification Market: Regional Outlook
  • 9.2. North America
    • 9.2.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. Competitive scenario
      • 9.2.2.3. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Competitive scenario
      • 9.2.3.3. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key country dynamics
      • 9.2.4.2. Competitive scenario
      • 9.2.4.3. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Competitive scenario
      • 9.3.5.3. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Competitive scenario
      • 9.3.6.3. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.7. Norway
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Competitive scenario
      • 9.3.7.3. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Competitive scenario
      • 9.3.8.3. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.9. Denmark
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Competitive scenario
      • 9.3.9.3. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. MEA market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Competitive scenario
      • 9.6.3.3. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Competitive scenario
      • 9.6.4.3. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Competitive scenario
      • 9.6.5.3. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. QIAGEN
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Illumina, Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Danaher
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. F. Hoffmann-La Roche Ltd
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Merck KGaA
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Agilent Technologies
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Bio-Rad Laboratories, Inc.
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Takara Bio Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Promega Corporation
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives